Development of vaccines against SARS-CoV-2

Abstract

The development of effective vaccines against the SARS-CoV-2 is considered a higher global public health priority to control the transmission and spread of the disease. Different approaches have been proposed to design and develop vaccines for COVID-19, these include epitope-based peptide vaccines, recombinant protein vaccines, viral vector vaccines, nucleic acid-based vaccines, and inactivated vaccines. However, until May 2020, there is not approved vaccine against COVID-19.